-
Egypt Revokes Citizenship of Brothers Anas and Tarek Habib Over Unapproved Foreign Nationality
-
UCLA Stays Unbeaten With Ty Dieffenbach's Heroic Return Against Illinois
-
2027 Rivian R2 Performance vs. 2026 Jeep Recon Moab: EV Comparison Test
-
Malta Court Rejects Libel Claims by Developer Kurt Buhagiar Against MEP Peter Agius
-
Henan Grave Carved with Herbal Prescriptions Draws Hundreds of Visitors Daily
-
Neo Nontso Reveals Anele Mdoda’s Calm Demeanor During Wedding Prep
-
NCLT Chennai Orders Insolvency Proceedings Against Orchid Pharma Founder K Raghavendra Rao
AstraZeneca buys US biotech firm CinCor
Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.
The takeover marks the latest push by Astra chief executive Pascal Soriot to bolster the Covid vaccine maker's pipeline of new products.
Massachusetts-based CinCor focuses on developing treatments for hypertension and chronic kidney disease.
Since taking the helm at AstraZeneca in 2012, Frenchman Soriot has expanded the company into lucrative cancer therapies.
The group completed a blockbuster takeover of Alexion for $39 billion in 2021, giving it more heft in areas such as treating blood disorders.
E.Schubert--BTB